A Physiologically‐Based Pharmacokinetic Model for Targeting Calcitriol‐Conjugated Quantum Dots to Inflammatory Breast Cancer Cells

Clinical and Translational Science - United Kingdom
doi 10.1111/cts.12664
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Physiologically-Based Pharmacokinetic Model for Vancomycin

SIAM Undergraduate Research Online
2016English

Physiologically Based Pharmacokinetic (PBPK) Model of Ivermectin (IVM)

English

Nanocarrier Based Approaches for Targeting Breast Cancer Stem Cells

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2017English

Quantum Dots Based Probes Conjugated to Annexin v for Photostable Apoptosis Detection and Imaging

English

Graphene Quantum Dot-Based Theranostic Agents for Active Targeting of Breast Cancer

RSC Advances
ChemistryChemical Engineering
2017English

The Implications of Using a Physiologically Based Pharmacokinetic (PBPK) Model for Pesticide Risk Assessment

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
2010English

Physiologically Based Pharmacokinetic Model of Lapatinib Developed in Mice and Scaled to Humans

Journal of Pharmacokinetics and Pharmacodynamics
Pharmacology
2013English

Accumulation and Distribution of Non-Targeted and Anti-Cd44-Conjugated Quantum Dots in Distinct Phenotypes of Breast Cancer

Journal of Nanomedicine & Nanotechnology
2015English

Simulating Intestinal Transporter and Enzyme Activity in a Physiologically Based Pharmacokinetic Model for Tenofovir Disoproxil Fumarate

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy